PICO Portalanswers from OpenAlex & ORCID
Keun‐Wook Lee
ResearcherPublications, citations & collaboration network
Keun‐Wook Lee is a researcher indexed in PICO Portal from OpenAlex & ORCID.
How many works does Keun‐Wook Lee have?
PICO Portalindexed works
Keun‐Wook Lee has 507 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Keun‐Wook Lee have?
PICO Portalcitation count
Keun‐Wook Lee has 16,303 citations in the OpenAlex counts PICO Portal stores.
What is the h-index of Keun‐Wook Lee?
PICO Portalh-index
Keun‐Wook Lee has an h-index of 56 in OpenAlex.
What is the i10-index of Keun‐Wook Lee?
PICO Portali10-index
Keun‐Wook Lee has an i10-index of 202 in OpenAlex.
What is the ORCID of Keun‐Wook Lee?
PICO Portalorcid
The ORCID for Keun‐Wook Lee is on the source record.
What is the OpenAlex record for Keun‐Wook Lee?
PICO Portalopenalex
The OpenAlex for Keun‐Wook Lee is on the source record.
What are the most-cited papers on Keun‐Wook Lee?
PICO Portalmost cited works
Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project
Bo Hwa Sohn, Jun‐Eul Hwang, Hee-Jin Jang, Hyun‐Sung Lee, Sang Cheul Oh, Jae‐Jun Shim, Keun‐Wook Lee, Eui Hyun Kim, Sun Young Yim, Sang Ho Lee, Jae‐Ho Cheong, Woojin Jeong, Y. Choi, Joo‐Hee Kim, Jungsoo Chae, Jeeyun Lee, Jeeyun Lee, Won Ki Kang, Sung Hoon Noh, Sung Hoon Noh, Jaffer A. Ajani, Ju‐Seog Lee, Ju‐Seog Lee
Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trial
Rui‐Hua Xu, Kei Muro, Satoshi Morita, Satoru Iwasa, Sae Won Han, Wei Wang, Masahito Kotaka, Masato Nakamura, Joong Bae Ahn, Yan‐Hong Deng, Takeshi Kato, Sang‐Hee Cho, Yi Ba, Hiroshi Matsuoka, Keun‐Wook Lee, Tao Zhang, Yasuhide Yamada, Junichi Sakamoto, Young Suk Park, Tae Won Kim